Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Numinus Wellness Inc

NUMIF
Current price
0.036 USD +0.012 USD (+50.00%)
Last closed 0.035 CAD
ISIN CA67054W1032
Sector Healthcare
Industry Medical Care Facilities
Exchange TO
Capitalization 9 625 555 CAD
Yield for 12 month -57.69 %
1Y
3Y
5Y
10Y
15Y
NUMIF
21.11.2021 - 28.11.2021

Numinus Wellness Inc. provides psychedelic-assisted psychotherapy products and services in Canada and the United States. The company operates through Clinical Research Operations, Canadian Clinic Network, and U.S Clinic Network segments. The Clinical Research Operations segment offers clinical research management services to academic institutions and biotechnology companies. The Canadian Clinic Network segment provides clinical services, including traditional therapy and counseling, ketamine-assisted therapies for depression, psychedelic-assisted therapies, mindfulness programs, and virtual psychotherapy services, as well as neurological care services. The US clinic network segment offers psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management services. The company also offers laboratory services, such as the cultivation, production, and extraction of natural Psilocybe and other psychoactive fungi species, the development of proprietary processes and products, methods for controlled psychedelics and development of a pipeline for product development, and protocol development and safety and efficacy studies; lab testing services; and psychedelic-assisted therapy training services. The company was incorporated in 1964 and is headquartered in Vancouver, Canada. Address: 666 Burrard Street, Vancouver, BC, Canada, V6C 2X8

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1.53 CAD

P/E ratio

Dividend Yield

Current Year

+23 202 181 CAD

Last Year

+6 500 148 CAD

Current Quarter

+4 352 849 CAD

Last Quarter

+5 004 677 CAD

Current Year

+8 379 221 CAD

Last Year

+1 778 432 CAD

Current Quarter

+669 106 CAD

Last Quarter

+1 261 735 CAD

Key Figures NUMIF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -19 981 441 CAD
Operating Margin TTM -90.97 %
PE Ratio
Return On Assets TTM -51.49 %
PEG Ratio
Return On Equity TTM -187.91 %
Wall Street Target Price 1.53 CAD
Revenue TTM 22 502 168 CAD
Book Value 0.014 CAD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -16 %
Dividend Yield
Gross Profit TTM 1 778 432 CAD
Earnings per share -0.08 CAD
Diluted Eps TTM -0.08 CAD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -113.23 %

Dividend Analytics NUMIF

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History NUMIF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date 20.05.2020

Stock Valuation NUMIF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.5779
Price Sales TTM 0.4278
Enterprise Value EBITDA -1.3737
Price Book MRQ 2.0762

Financials NUMIF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators NUMIF

For 52 weeks

0.025 CAD 0.2 CAD
50 Day MA 0.031 CAD
Shares Short Prior Month 411 172
200 Day MA 0.067 CAD
Short Ratio 0.48
Shares Short 129 130
Short Percent